And Refractory Multiple Myeloma
📧 Sign up to get email alerts when something new happens for And Refractory Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating the tolerability of REGN17372 in combination with Linvoseltamab for adults with relapsed and refractory mult…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
An early-phase (Phase 1) trial update for SL4903 CAR-T therapy targeting relapsed/refractory multiple myeloma; the study is not yet recruiti…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
A registry study in Chinese patients with relapsed and refractory multiple myeloma treated with elranatamab is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Status update on a non-interventional study evaluating the safety and effectiveness of elranatamab in patients with relapsed and refractory …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM [Phase 1, Phase 2]
A clinical trial update describes a sub-study of belantamab mafodotin in combination with nirogacestat for relapsed and refractory multiple …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.